Summary
A SECOND bidder has entered the fray for what remains of PPL Therapeutics, the beleaguered former biotechnology pioneer.
The company revealed the approach yesterday as it unveiled a post- tax loss of (pounds) 16.5m for calendar 2003, compared with (pounds) 18.6m loss the previous year. Income, including grants and the sale of intellectual property, was unchanged on 2002 at (pounds) 1.2m.See the full content of this document
Extract
Dolly the Sheep Firm May Be Saved From Abattoir As Second Bidder Enters the Fray
Edinburgh-based PPL, which has been selling off its remaining assets, said several weeks ago that ...
See the full content of this document
Sponsored links
